Tag: COVID-19

Inter-CEPt

UK study striving to Inter-CEPt home dialysis discrepancies before they become...

As highlighted by previous studies, as well as the Getting It Right First Time (GIRFT) national report on renal medicine and data from the...

Select solid-organ transplant recipients may remain at high Omicron risk despite...

While a fourth vaccine dose does increase anti-spike immunoglobin-G (IgG) and neutralising capacity against many COVID-19 variants of concern (VOCs), some solid-organ transplant recipients...
uk renal registry

UK Renal Registry: Peritoneal dialysis climbs despite overall RRT decrease

With comprehensive UK Renal Registry (UKRR) data from 2020 set to be published by the UK Kidney Association (UKKA) imminently, Renal Interventions previews a...

Study affirms increased access and equity for COVID-19 vaccines administered in...

A federal partnership established to help increase access to COVID-19 vaccines for end-stage kidney disease (ESKD) patients receiving dialysis was successful in reducing racial...

DaVita Clinical Research study finds efficacy of common COVID-19 vaccines at...

Dialysis patients who received an adenovirus vector-based COVID-19 vaccine (Johnson & Johnson) were found to have similar rates of breakthrough infection, hospitalisation and mortality...

Standard vaccination regimens may not provide adequate protection against new SARS-CoV-2...

Kidney transplant recipients tend to mount impaired antibody responses against emerging SARS-CoV-2 variants after standard two-dose COVID-19 vaccination, according to a study published in the...

DaVita Clinical Research study indicates mRNA COVID-19 vaccines effective in dialysis...

Dialysis patients who received mRNA COVID-19 vaccines had a lower risk of COVID-19 diagnosis post-vaccination, and were less likely to be hospitalised or die...

ASN Kidney Week: Research uncovers why dialysis and transplant patients are...

People with kidney failure who are on dialysis or who have received a kidney transplant face a higher risk of dying from COVID-19—and new...
kidney transplantation covid-19

ESOT 2021: Kidney transplants plummeted by 40% during first wave of...

The number of solid organ transplants performed during the first wave of the COVID-19 pandemic in 2020 plunged by nearly a third (31%) compared...

Pilot study of third COVID-19 vaccine dose in kidney transplant recipients...

A pilot study has begun to assess the antibody response to a third dose of an authorised COVID-19 mRNA vaccine in kidney transplant recipients...
covid-19 vaccine dialysis patients

Nationwide survey indicates hesitancy among US dialysis patient groups over COVID-19...

A nationwide survey distributed among 150 randomly selected dialysis facilities in the USA has found that a “substantial proportion” of patients receiving in-centre haemodialysis...
covid-19 vaccine dialysis patients

US Renal Care distributes second round of COVID-19 vaccines to dialysis...

Dialysis provider US Renal Care recently announced it has finished administering a second round of mRNA vaccines to ensure better protection against COVID-19 for...

Arteriovenous fistulas contribute to higher survival of haemodialysis patients with COVID-19

A new study, published online in The Journal of Vascular Access (JVA), suggests that arteriovenous fistulas (AVFs) contribute to higher survival of haemodialysis patients...

Fresenius Medical Care makes dialysis clinics available for COVID-19 vaccination

Fresenius Medical Care has made its own dialysis clinics available for the vaccination of its patients against COVID-19. Dialysis patients are an especially high-risk group...

Algorithm predicts dialysis, and death from critical illness in hospitalised COVID-19...

Acute kidney injury (AKI) treated with dialysis is reported to be a frequent complication in patients hospitalised with COVID-19. Research published online in the...

Study provides new insights on COVID-19 risk in patients receiving dialysis

Many individuals with kidney failure have been unable to self-isolate during the COVID-19 pandemic because they require dialysis treatments in clinics several times a...
invizius

Invizius raises £5.3 million to assess anti-inflammatory treatment for haemodialysis patients

Invizius has announced the closing of a Series A financing round worth £5.3 million. The Scottish biotechnology company will use this funding to complete...

Dialysis access needs to be a priority in the COVID-19 era

Panagiotis M Kitrou and Nicholas Inston discuss the impact of the COVID-19 pandemic on vascular access services. Despite the disruption caused, they are optimistic...